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Abstract: Novel sensor-based continuous biomedical monitoring technologies have a major role in chronic disease 
management for early detection and prevention of known adverse trends. In the future, a diversity of 
physiological, biochemical and mechanical sensing principles will be available through sensor device 
‘ecosystems’.  In anticipation of these sensor-based ecosystems, we have developed Healthcare@Home 
(HH) - a research-phase generic intervention-outcome monitoring framework. HH incorporates a closed-
loop intervention effect analysis engine to evaluate the relevance of measured (sensor) input variables to 
system-defined outcomes. HH offers real-world sensor type validation by evaluating the degree to which 
sensor-derived variables are relevant to the predicted outcome. This ‘index of relevance’ is essential where 
clinical decision support applications depend on sensor inputs.  HH can help determine system-integrated 
cost-utility ratios of bespoke sensor families within defined applications – taking into account critical 
factors like device robustness / reliability / reproducibility, mobility / interoperability, authentication / 
security and scalability / usability. Through examples of hardware / software technologies incorporated in 
the HH end-to-end monitoring system, this paper discusses aspects of novel sensor technology integration 
for outcome-based risk analysis in diabetes. 
1 INTRODUCTION 
Continuous sensor-based monitoring technologies 
are central to new models of ‘proactive’ health and 
social care.  In healthcare, ‘proactive’ implies a shift 
away from ‘reactive’ care – i.e. an ‘illness-centric’ 
model where interventions are made following 
presentation of symptoms or complications.  The 
‘proactive’ model embraces the World Health 
Organisation’s (WHO) definition of health as “a 
state of complete physical, mental and social well-
being and not merely the absence of disease or 
infirmity” (WHO, 2007).  To move towards this 
 visionary goal, individuals need realistic 
opportunities to improve and sustain their health and 
quality of life thus contributing to their own well-
being.  The availability of validated, relevant and 
ubiquitous personal healthcare information to 
minimise risk of predictable adverse events can 
empower and incentivise individuals to adopt more 
healthy lifestyles. Such technology can assist care 
throughout the ‘patient path’ (Abidi, 2001; 
Shnayder, 2005). Arising from these technology 
developments are significant ethical issues - e.g. in 
personal data protection and in establishing ethical 
authority for personal data reuse. We will discuss 
these issues in detail elsewhere in the context of our 
Healthcare@Home (HH) project - a research-phase 
generic intervention-outcome monitoring framework 
that integrates sensor-based technology as part of a 
disease early detection and prevention framework.  
 
It is widely anticipated that future health 
information systems (HIS) will need to move from 
“institution-based” models to those that rely on ‘near 
real time’ data integration close to the patient.  
Interventions that use ethical risk stratification as 
part of a personal data integration framework is a 
priority in diabetes, where the number of affected 
individuals is predicted to rise from c.135 million 
people in 1995 to c.300 million in 2025 (King, 
1998).  All people with unmanaged diabetes are at 
substantially increased risk of serious medical 
complications such as retinopathy, kidney failure 
and peripheral neuropathy requiring limb 
amputation.  As part of an individual’s personal 
information management, the HH closed-loop model 
uses sensor-based trends to compute and stratify risk 
in a time frame and operational workflow that is 
meaningful and in a format that can be utilised for 
building decision support services (DSS).  The DSS 
model in HH is founded on requirements of the 
Diabetes National Service Framework (NSF) 
standards for Wales and associated integrated care 
pathways (ICP). Section 2 summarises relevant 
related work. Section 3 describes technical aspects 
of the end-to-end HH system covering (1) smart 
sensors; (2) biometric authentication; (3) ‘home hub’ 
and (4) server-side architecture.  Section 4 discusses 
concerns arising out of the project and possible 
future work with a conclusion in Section 5. 
2 RELATED WORK 
A healthcare technology platform utilising sensor 
devices can underpin comprehensive monitoring 
services outside of the hospital environment.  This 
could support new ways of working that: (1) places 
less reliance on frequent clinical visits – subject to 
quality control / calibration safeguards and adequate 
clinical ‘baseline’ data (2) can incentivise patients to 
‘look after themselves’ with realistic (achievable) 
personal guidelines within manageable episodes of 
care; (3) allows team-based caseload sharing 
between clinical visits to monitor progress and make 
escalation procedures robust (4) provides for the 
development of consistent risk prediction / 
longitudinal ‘outcome recording’ methodologies that 
are fit-for-purpose in scaleable evidence-based 
models (Williams, 2003; Conley, 2007). Several 
research projects address the issue of integrated care 
through the use of ubiquitous computing devices.  
SAPHIRE (Hein 2006) is concerned with 
developing a healthcare monitoring and decision 
support system for cardiovascular disorders, assisted 
by wireless sensor devices in home settings.  
(Clemensen 2004) applied pervasive computing 
devices to the treatment / monitoring of diabetic foot 
ulcers. The CODEBLUE project (Lorincz, 2004) is 
typical of sensor device applications in medical 
emergency scenarios. In this project, micro-scale 
sensor devices (motes) (Crossbow, 2007) have been 
used to continuously monitor and wirelessly transmit 
vital sign data (e.g. heart rate and oxygen saturation 
data) to a data hub for processing. The CART 
(continuous automated real-time triage) system, 
developed by Advanced Health and Disaster Aid 
Network (AID-N) builds on the work carried out by 
the CODEBLUE team.  A wearable tag has been 
developed which performs the following functions: 
triage, status display, vital signs monitoring, location 
tracking, information display and alarm signalling 
(Gao, 2006).  The Smart and Aware Pervasive 
Healthcare Environment (SAPHE, 2007) supports 
telecare and lifestyle monitoring paradigms for early 
detection and prevention of adverse events i.e. for 
intervention before they become critical or life-
threatening.  Several remote healthcare monitoring 
systems are that currently use proprietary device 
information systems (e.g. Honeywell, American 
Telecare and AMD Telemedicine).  Many more 
device families are expected to be developed in 
coming years conforming to global standards being 
established by the Continua Healthcare Alliance 
companies (Continua, 2007).  
 
The HH system’s conceptual driver is enabling 
‘near real time’ risk analysis for early detection and 
prevention of disease.  A Web Services-based 
platform to ‘push’ or ‘pull’ individual’s health-
related data along the patient path is being 
configured in a manner that will reduce 
transcriptional errors. The end-to-end framework 
 (Figure 1, see below) employs a collection of 
clinical hubs, mobile devices and / or dedicated 
home-based network servers to one or more data 
analysis engines. 
3 END-TO-END FRAMEWORK 
Figure 1 illustrates the conceptual design of an ‘end-
to-end’ framework adopted in the HH project. The 
framework allows data capture from both wearable 
sensors and specialist hand-held instruments with 
wireless data transfer capability. Through a 
messaging fabric and / or dedicated integration 
application, raw data used in the risk analysis 
modules may originate from a wide variety of 
sources and device types (e.g. electronic forms, 
physiological monitors, retinopathy cameras, 
scanners, clinical chemistry or nucleic acid 
sequencing instrumentation). The data is integrated 
using a schema indicated as “QUID” (QUantitative 
Individualised Data integration) in the figure. In the 
context of an ‘initial assessment’ workflow, the 
types of diagnostic test to be performed are specified 
by a clinical registration procedure to be described 
elsewhere. The registration procedure has specific 
functions to ensure compliance to ethical protocols 
and informed consent procedures for re-use of data 
while verifying patient identity (see below). HH has 
adopted the Diabetes Continuing Care Reference 
(DCCR) dataset as the basis of its schema). 
Subsequent risk analysis of baseline data is 
undertaken in the context of a “disease model” - a 
quantitative research-based predictive framework 
that indicates which risk variables are most relevant 
to system-specified outcomes. In this regard, HH has 
been conceived as a comprehensive healthcare 
outcomes evidence-based learning platform. 
 
3.1 Smart sensors 
In monitoring applications, the most common 
physiological analytes are blood gases (e.g. carbon 
dioxide, oxygen), blood electrolytes (e.g. potassium, 
sodium, and chloride), blood glucose, creatinine, 
urea, pH, cholesterol, bilirubin and proteins (e.g. 
albumin).  The relative significance of values 
depends on the type of investigative scenario and 
progression status of disease.  In diabetes, the 
measurement of glucose concentration at an 
appropriate frequency is routine in short-term 
prevention of hyper- and hypo-glycaemic events and 
in long-term prevention of complications. 
Automated measurements can be enabled to support 
continuous monitoring.  Conventionally, glucose 
monitoring is performed using ‘finger-stick’ devices.  
These provide only intermittent measurements and 
rely on patient compliance.  Next-generation glucose 
monitoring devices aim to provide real-time 
continuous measurements by non- or minimally-
invasive means.  One such sensor designed for 
integration into the HH system uses glucose-
responsive holograms based on thin-film polymers 
 
Figure 1: HH end-to-end framework 
 incorporating phenylboronic acid receptors. 
Selective binding of glucose to the receptors induces 
swelling or contraction of the film.  This physical 
change in turn causes the spacing between 
holographic fringes within the film to increase or 
decrease, thereby modulating the colour of the light 
diffracted according to Bragg’s Law.   
 
To obtain repeatable quantitative measurements 
(figure 2), the colour of the hologram can be read 
with a portable optical reader equipped with 
Bluetooth®.  These sensors exhibit long-term 
chemical and physical stability, enabling 
measurements over long time periods without 
evidence of hysteresis.  A further advantage is the 
ability of holographic analyte sensors to be 
incorporated into a multitude of formats (e.g. 
catheters, contact lenses, implants), thereby offering 
increased patient choice.   
 
 
The prototype hand-held device (figure 3) has a 
touch-screen user interface. The reader employs a 
bespoke spectrometer optical sub-assembly, 
combined with analogue to digital converters 
(ADCs).  These ADCs are read by a microprocessor 
which provides a calibrated output of wavelength 
and the corresponding concentration of the analyte 
being measured.  This is achieved by use of look up 
tables or calibrated polynomial curve fit data.  
Temporal data trends can be calculated on-device or 
data can be sent via Bluetooth® to a HH web service 
to enable downstream decision support. 
 
3.2 Biometric authentication 
The HH system design has evaluated scenarios 
where people entering data might be easily confused 
by similar names or as different members of the 
same family. A number of protocols for 
disambiguation and absolute patient identification 
can be incorporated, including biometrics and / or 
smartcards. Biometric variables can be classified 
either as physiological (e.g., derived from a 
fingerprint, face or iris scan) or behavioural (e.g., 
speech recognition) (Biometrics, 2007). 
  
The HH system requires technology options that 
are cost-effective, fast and accurate.  Based on these 
criteria, biometric identification used robust 
fingerprint recognition technology (‘2’ in figure 1) 
(Wilson 2003).  For flexibility, the biometrics device 
was designed to be “loosely-coupled” with the 
sensor and the home hub modules (refer to section 
3.3).  This permitted different packaging options 
with integration of new sensor types without 
substantial additional engineering cost.  The hub is 
used to tag the biometric ID to the incoming sensor 
data in order to form an association between a 
patient identity and a data reading.  Communication 
between sensor, home hub and the biometrics 
module is via Bluetooth®, using a protocol specified 
by IBM, Zarlink and Smart Holograms.  
 
In its current operational mode, the biometric 
device (figure 4) used in the HH system saves the 
scanned fingerprint of a user in local memory, and 
the individual is prompted to assign an “ID” specific 
to that fingerprint.  That ID is then transmitted via 
Bluetooth® to the data hub to be tagged within an 
electronic patient record.  This “enrolment” process 
can be used prior to sensor readings to validate 
identity. A delay-free smartcard that has high end-
user acceptance (e.g. contact-less ‘wave & pay’ 
 
Figure 2: Real-time measurement of blood glucose 
using a holographic sensor compared to 
measurements made off-line and post experiment 
by a traditional reference method. 
 
Figure 3: Smart Holograms prototype Hologram 
reader with integrated Bluetooth® connectivity. 
 cards) can also be used in appropriate circumstances 
e.g. to enable inter-service access along the patient 
path. Identification of the patient by means of their 
enrolled ID sends that ID to the patient-proximal 
hub (in the clinical data ‘baseline data’ operational 
hub or the patient’s own home hub, or mobile hub).   
The home hub can associate the subsequent sensor 
reading with the patient ID.  This is the 
“identification” process.  The design of the device 
ensures security of patient information. All scanned 
fingerprints are stored in the memory of the 
biometric device.  No fingerprint scans are 
transmitted.  All patient-identifiable information can 
be encrypted at source, in transmission and storage. 
If a hacker were to capture the wireless 
transmissions the data would have no meaning. 
 
3.3 Home Hub 
The function of the ‘home hub’ (‘3’ in figure 1) is to 
collect and collate the data from sensor(s) and the 
biometric and smartcard / reader device(s) and to co-
transmit these via an appropriate communication 
channel to the remotely-located server. The home 
hub sits at the centre of the data collection and 
transmission capability of the system, where all 
devices - sensors, authentication module and server 
connect through common interfaces. Various 
physical realizations of the hub are possible. It can, 
for example, be a mobile device such as a standard 
mobile phone (we have demonstrated functionality 
on a Sony Ericsson P910 phone - figure 5) that can 
provide near real-time data connectivity.  The hub 
can also be deployed as a fixed ‘wired’ hub using, 
for example, Ethernet connectivity. In a clinical 
environment this also provides near real-time data 
connectivity. For home use, hubs can be configured 
to upload data periodically e.g. once or twice a day.  
 
 
Figure 5: Mobile phone personal data hub by IBM 
 
Sensor devices currently connect to the hub 
through adapters specific to the type of interface 
required. Adapters are device transmission protocol 
specific and can be developed by any manufacturer 
wanting to provide connectivity of their devices to 
this infrastructure. In HH, the medical devices use 
Bluetooth®, although the architecture allows for this 
to be any available. Zigbee has some power 
consumption advantages over Bluetooth® (Zigbee, 
2007). 
 
We have developed adapters for a variety of 
devices that can be used in conjunction with the 
demonstrator system; namely for: (1) weighing 
scales; (2) blood pressure cuff; (3) pulse oximeter; 
(4) glucose meter.  In addition to adapters for sensor 
devices, an adapter is also required to interface the 
hub to an appropriate application server. This step is 
also protocol-specific and in practice a range of 
adapters may be needed according to specific 
application scenarios.  
 
The hub architecture (figure 6) consists of an 
event engine that behaves much like a broker, in that 
it can receive events from one adapter and passes 
these onto another adapter. In the simplest operation, 
the event engine receives events from a single sensor 
device (for example, weighing scales) and sends this 
event to the adapter that transmits these events to an 
application server.  The current implementation of 
this architecture uses the IBM Personal Care 
Connect toolkit (Blount, 2007) and is based around a 
number of standard technologies.  These include: 
• Java 2, Micro Edition, Mobile Information 
Device Profile, Connection-Limited Device 
Configuration (J2ME, MIDP, CLDC) or OSGI 
for fixed hub (Java ME, 2007). 
• JSR-82 to allow Java to interface to Bluetooth® 
(assuming Bluetooth-enabled medical devices) 
(JSR 82, 2007). 
 
Figure 4: Fingerprint scanner by Zarlink  
 • Bluetooth® or mobile connectivity via GSM / 
GPRS for wireless hubs. 
• Ethernet, ISDN, etc. for fixed / wired hubs.  
 
 
The hub design supports multiple adapters – key 
to creation of an open-hub platform. Each adapter is 
specific to a hub family, which is characterised by 
the following attributes: (i) device-to-hub 
communication, (ii) event data representation, (iii) 
event serialisation, and (iv) hub-to-server 
interaction. Different hub families can use different 
event classes, communication protocols, and 
serialisation schemes. A hub family may be 
optimised to handle a specific set of biomedical 
sensor types. Each adapter handles communication 
with a family of hubs by (i) defining a protocol, (ii) 
de-serialising the data forwarded by the hub, and 
(iii) extracting event data from the event after 
instantiating the events.  Adapters also convert 
proprietary data events into a consistent format – i.e. 
act as a definable interface.  It is expected that HH 
will migrate to industry recommendations of 
consortia such as the Continua Alliance (Continua, 
2007).  The hub functionality is currently 
implemented in Java and is deployable to a mobile 
phone as a MID-let or to a fixed hub as a set of 
OSGI bundles. 
 
In the current research demonstrator, sensor data 
can be obtained from devices and stored on the hub 
prior to transfer by a standard HTTP protocol. A 
HTTP ‘Post’ agent uses stable storage to cache 
events that cannot be sent immediately and then 
forwards them when the next connection to the 
server is established. Data sent to the server is 
secured using the Secure Sockets Layer (now 
referred to as Transport Layer Security) (SSL, TLS). 
Other options include: Access Point Node (APN) 
and Virtual Private Network (VPN).  
 
Secure Sockets Layer: SSL is commonly used 
within internet applications to provide secure client 
to web server connections.   
 
Access Point Node: The Access Point Node (or 
Name) is the definition of the internet connection on 
a GPRS mobile device that provides the route the 
data will take from the GPRS device to access other 
networks such as the Internet. All APN’s are defined 
within the mobile device with a username and 
password. The APN concept assumes the existence 
of GPRS support nodes that exist between a mobile 
device (using a GSM or UMTS service) and a server 
providing IP-based access to the Internet.  By 
obtaining a private APN (with its own unique 
credentials) it is possible to create a private 
connection back to the HH servers.  The HH 
demonstrator has been successfully tested with APN. 
 
Virtual Private Network: A VPN effectively 
creates a private network by creating a secure 
‘tunnel’ through the existing IP network. The HH 
demonstrator has successfully used the IBM VPN 
product WebSphere Everyplace Connection 
Manager (WECM).  
 
A sub-class of specialised functions that mimic 
adapters exist to create functions internal to the hub. 
A number of these have been implemented within 
the current demonstrator.  For example, an “Audio 
Alert Agent” makes pre-configured audio alerts in 
response to certain events like the reception of data 
from a device or successful transmission of an event 
to the server.  The “User Display Agent” enables the 
display of status information and provides input 
capability for the user.   
 
3.4 Server-side architecture 
The server-side architecture comprises of a ‘QUID’ 
and ‘QUIRA’ component (figure 7 and ‘4’ in figure 
1) and has been described in detail elsewhere 
(Subramanian, 2006, Shaikh-Ali, 2007, Conley, 
2007).   
 
The QUID component focuses on delivering data 
collection, data storage, process execution and portal 
infrastructures to support users of the system 
including clinicians, patients and researcher roles. 
The development of QUID has been guided by the 
 
Figure 6: Hub technical overview 
 .
requirements of Integrated Care Pathways (ICPs) for 
diabetes (ICP, 2007).  The QUID component 
collects, validates and stores data streams from hubs 
along the patient path.  The interface for data 
presentation / collection emulates workflows in real-
world care pathways. This ‘end-user familiarity’ 
design feature is strengthened by presentation of the 
sensor data in a timeline-based (longitudinal) 
layered manner, make the data meaningful.  We 
have used OpenLaszlo (Laszlo, 2007) to display 
charts in an intuitive manner. Similarly, the patient 
portal permits access to personal data supporting the 
self-management paradigm 
 
The QUIRA (Quantitative Individualised Risk 
Analysis) component comprises a risk analysis 
engine performing various operations identifying 
signals in the longitudinal data stream, alerting the 
care team to fulfilment of pre-defined risk criteria. 
QUIRA represents ongoing research we will report 
on in the future. 
4 CONCERNS & FUTURE WORK 
“Pervasive” or “ubiquitous” computing covers a 
range of research topics, including distributed 
computing, mobile computing, sensor networks, 
communications, artificial intelligence, and human-
computer interaction.  It is an emerging field of 
research, and as such has many unresolved issues – 
notably in areas like security, usability, privacy and 
ethics amongst others.  In the framework described 
in this paper, ubiquitous computing devices demand 
secure transmission of data to the server, in turn 
demanding encryption mechanisms that defeat 
purposeful or accidental ‘eavesdropping’.  Device 
miniaturisation assists the resolution of powering 
issues. Significant ethical and privacy issues remain, 
and it is axiomatic that a comprehensive informed 
consenting process needs to be developed that is fit-
for-the defined purpose of disease early detection 
and prevention. Informed consent needs to be 
properly structured in the recording workflow.  
 
There is currently no widely-accepted standard 
protocol for the device-to-server data transmission 
and / or format / structure for data being transferred 
between devices.  We expect interoperability 
between devices from different vendors to be a key 
focus within the scope of the Continua Healthcare 
Alliance (Continua, 2007). Irrespective of global 
technical standards adopted, methodological 
standardisation of data acquisition needs to be 
defined in order for patients and carers to reap the 
benefits of interoperable systems. 
 
The HH project has to date employed non-
invasive sensors. However we anticipate significant 
developments in coming years in the area of 
invasive (implantable) sensors.  Implantable sensors 
will likely be micro-miniaturised devices that can be 
implanted into a patient’s body to enable relaying of 
health-critical signals on a semi-continuous basis. 
5 CONCLUSION 
System-based management of chronic conditions is 
essential to improve healthcare outcomes.  
Conventional models of healthcare provision lack 
capacity to continuously monitor physiological data 
 
Figure 7: Physical implementation of the conceptual design shown in Figure1 
 combined with life event ‘timelining’. In such an 
information system, healthcare can be provided in a 
‘patient-centric’ model that maximises healthcare 
resources.  
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